Association study of the let-7 miRNA-complementary site variant in the 3' untranslated region of the KRAS gene in stage III colon cancer (NCCTG N0147 Clinical Trial).
about
The Regulatory Roles of MicroRNAs in Bone Remodeling and Perspectives as Biomarkers in OsteoporosisImplications of mismatch repair-deficient status on management of early stage colorectal cancerMicroRNAs as growth regulators, their function and biomarker status in colorectal cancerMicroRNAs in Cancer: A Historical Perspective on the Path from Discovery to TherapyMicroRNA regulation of tumorigenesis, cancer progression and interpatient heterogeneity: towards clinical useDeregulation of miR-193b affects the growth of colon cancer cells via transforming growth factor-β and regulation of the SMAD3 pathwayMicroRNA-mediated regulation of KRAS in cancerManipulating miRNA Expression: A Novel Approach for Colon Cancer Prevention and ChemotherapyPrognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: results of the EXPERT-C trial.Microsatellite instability testing and its role in the management of colorectal cancer.Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients.MicroRNAs: New Insight in Modulating Follicular Atresia: A Review.MicroRNA dysregulation as a prognostic biomarker in colorectal cancerRegulatory miRNAs in Colorectal Carcinogenesis and Metastasis.Discovery of Potential Therapeutic miRNA Targets in Cardiac Ischemia-Reperfusion Injury.miR‑3147 serves as an oncomiR in vulvar squamous cell cancer via Smad4 suppression.Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors.
P2860
Q26748699-BA195EBE-0CC6-4C8F-A54A-F8AFC1D68D8FQ26772272-CFFF9760-C1B7-4234-9B07-987DE3D51178Q26775610-C16D12A5-B3B3-4C3C-A5FD-24B383CE45FDQ26801487-83BB2B6E-94CE-4A50-9CD0-1F3549089663Q26861185-42D20D32-6A9B-44FD-841D-4BC53A0F7B5AQ33598197-4B609476-08F3-4C5B-B1D9-4581D7FD838EQ34678120-C498CEB5-0036-4A5A-974C-F10B653F643DQ35647187-41B8C3C3-AD49-4C20-833F-70004C1EE08BQ36000232-CA6435B5-8CDD-4613-A69A-C8046F5B2FF3Q36124008-271C7A17-E6FE-48A7-9BE4-279043EB71D8Q37225193-F11D12CF-0667-4C8F-9FA6-E2F8530B8DCFQ37690810-5B7CE331-6C71-4D5E-82D6-DC05D74E332FQ38262497-13C9534E-37B8-44A7-AB31-D7AA847B6B4CQ39261789-E6627343-83AB-4D07-B4A9-358975129990Q50932525-F8588623-B03F-40FE-94FA-C0383605A83FQ52670018-7D7591F9-114F-4F7A-88EE-586D12D86E79Q55403266-854B26DA-A6BF-40BC-9754-EF8CF10F2935
P2860
Association study of the let-7 miRNA-complementary site variant in the 3' untranslated region of the KRAS gene in stage III colon cancer (NCCTG N0147 Clinical Trial).
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Association study of the let-7 ...... (NCCTG N0147 Clinical Trial).
@ast
Association study of the let-7 ...... (NCCTG N0147 Clinical Trial).
@en
type
label
Association study of the let-7 ...... (NCCTG N0147 Clinical Trial).
@ast
Association study of the let-7 ...... (NCCTG N0147 Clinical Trial).
@en
prefLabel
Association study of the let-7 ...... (NCCTG N0147 Clinical Trial).
@ast
Association study of the let-7 ...... (NCCTG N0147 Clinical Trial).
@en
P2093
P2860
P1476
Association study of the let-7 ...... (NCCTG N0147 Clinical Trial).
@en
P2093
Adam M Lee
Frank A Sinicrope
Robert B Diasio
Steven R Alberts
P2860
P304
P356
10.1158/1078-0432.CCR-14-0069
P407
P577
2014-04-11T00:00:00Z